Student’s perspective about pharmacogenomic applications and knowledge in pharmacovigilance domain


  • G. Francis Britto Department of Pharmacology, IRT-PMC, Sanatorium (post), Perundurai, Erode, Tamilnadu, India
  • K. R. Subash Department of Pharmacology, SVIMS-Sri Padmavathi Medical College for Women, SVIMS University, Tirupati, Andhra Pradesh, India



Awareness, Doctors, Pharmacogenomics, Personalized medicine


Background: Pharmacogenomics has is presence now in all major pharmacology text books parallel with another important chapter pharmacovigilance. Pharmacogenomics apart from therapeutic application it can greatly influence standard treatment protocols with prevention of adverse drug reaction. Since the future will be physicians practicing personalized medicine, this study was planned to assess the second year M.B.B.S Students knowledge and their perspective about pharmacogenomic application.

Methods: A questionnaire to assess the knowledge about pharmacogenomics and current status of its application is formulated with yes or no, true or false option. The study was conducted on 120 M.B.B.S Students who passed out Pharmacology university exams. The questionnaires answered voluntarily were collected and the data was analysed and with results calculated in percentage.

Results: 80% M.B.B.S students had sound knowledge about pharmacogenomics. 100% M.B.B.S student’s doctors were well aware about pharmacogenomics. 13.0% of students were not aware but wanted to know about it, while 7.25% of students were neither aware nor interested about pharmacogenomics.

Conclusions: Most of the doctors were aware about the pharmacogenomics theoretically and they need to be updated about its clinical application in their practice by seminars, presentation and workshops.


O'Brien C. Pharmacogenetics. In: Brunton LB, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th Ed. New York, NY: McGraw-Hill; 2011:145-146.

The World Health Organization. Safety of Medicines: A Guide for Detecting and Reporting Adverse Drug Reactions. Geneva: WHO/EDM/QSM; 2002:110-140.

Prakash S. Pharmacovigilance in India. Indian J Pharmacol. 2007;39:123.

Jhunjhunwala A, Kumar N, Kumar R, Singh S, Dixit RK. A case study to know the level of awareness about pharmacogenomics and its clinical application among doctors of Lucknow, Uttar Pradesh, India. Int J Basic Clin Pharmacol. 2016;5:739-41.

Squassina A, Manchia M, Manolopoulos VG, Artac M, Lappa-Manakou C, Karkabouna S, et al. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogenomics. 2010;11(8):1149-67.

Lesko LJ. Personalized medicine: elusive dream or imminent reality? Clin Pharmacol Ther. 2007;81(6):807-16.

KD Tripathi. Aspects of Pharmacotherapy, Clinical Pharmacology and Drug Development In: Essentials of Medical Pharmacology 7th Ed. New Delhi: Jay Pee Publications; 2013:62-81.

Kudzi W, Addy BS, Dzudzor B. Knowledge of pharmacogenetics among healthcare professionals and faculty members of health training institutions in Ghana. Ghana Med J. 2015;49(1):50-6.

Stanek EJ, Sanders CL, Taber KA, Khalid M, Patel A, Verbrugge RR, et al. Adoption of pharmacogenomic testing by US physicians: results a nationwide survey. Clin Pharmacol Ther. 2012;91(3):450-8.

Johnson JA. Pharmacogenetics: potential for individualized drug therapy through genetics. Trends Genet. 2003;19(11):660-6.

Lesko LJ, Johnson JA. Academia at the crossroads: education and training in pharmacogenomics. Peris Med. 2012;9:497.




How to Cite

Britto, G. F., & Subash, K. R. (2017). Student’s perspective about pharmacogenomic applications and knowledge in pharmacovigilance domain. International Journal of Basic & Clinical Pharmacology, 7(1), 55–58.



Original Research Articles